Moreover, transmembrane channel-like 4 (TMC4) was found to have a low expression in the liver,5 which is consistent with no mechanistic data supporting its role in NAFLD. The gene discussed is TMC4; the disease is metabolic dysfunction-associated steatotic liver disease.